凱瑞康寧將參加美國2021專業睡眠協會年會並發表用於治療神經退化性疾病引起的睡眠障礙和發作性嗜睡症XW10172的安全性、耐受性和每日一次性長效製劑藥物動力學的臨床研究報告

0

美國加利福尼亞州紅木城和中國武漢, May 20, 2021 (GLOBE NEWSWIRE) — 凱瑞康寧今天宣佈,該公司開發用於治療神經退化性疾病所引起的睡眠障礙及發作性嗜睡症相關的新化合物分子實體(NCE)XW10172的臨床研究資料,將在2021年6月10日至6月13日舉行的美國專業睡眠協會(APSS)SLEEP 2021年會上進行簡報展示和演講介紹。

Stay connected with us on social media platform for instant update click here to join our  Twitter, & Facebook

We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.

Loading...

For all the latest Health News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Loading...
Denial of responsibility! TechiLive.in is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment